Alterations in RCAS1 serum concentration levels during menstrual cycle in patients with uterine leiomyoma and lack of analogical changes in adenomyosis

Gynecologic and Obstetric Investigation

Volumn 67, Issue 3, 2009, Pages 195-201

  Wicherek, Lukasz ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Adenomyosis; Endometriosis; Leiomyomatous uterus; Uterine myoma

Indexed keywords

MEMBRANE PROTEIN; PROTEIN RCAS1; UNCLASSIFIED DRUG;

ADENOMYOSIS; ADULT; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; LEIOMYOMATOSIS; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERUS MYOMA;

ADULT; ANTIGENS, NEOPLASM; ENDOMETRIOSIS; FEMALE; HUMANS; LEIOMYOMA; LEIOMYOMATOSIS; MENSTRUAL CYCLE; MIDDLE AGED; UTERINE DISEASES; UTERINE NEOPLASMS;

EID: 58149096841     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000188045     Document Type: Article

References (46)

1. Valle RF: Endometriosis: current concepts and therapy. Int J Gynaecol Obstet 2002; 78: 107-119.
2. Ulukus M, Cakmak H, Arici A: The role of endometrium in endometriosis. J Soc Gynecol Investig 2006; 13: 467-476.
3. Garai J, Molnar V, Varga T, Koppan M, Torok A, Bodis J: Endometriosis: harmful survival of an ectopic tissue. Front Biosci 2006; 11: 595-619.
4. Leyendecker G, Kunz G, Noe M, Herbertz M, Mall G: Endometriosis: a dysfunction and disease of the archimetra. Hum Reprod Update 1998; 4: 752-762.
5. Ulukus EC, Ulukus M, Seval Y, Zheng W, Arici A: Expression of interleukin-8 and monocyte chemotactic protein-1 in adenomyosis. Hum Reprod 2005; 20: 2958-2963.
6. Sampson JA: Endometrial carcinoma of the ovary, arising in the endometrial tissue of that organ. Arch Surg 1925; 10: 1-72.
7. Witz CA: Current concepts in the pathogenesis of endometriosis. Clin Obstet Gynecol 1999; 42: 566-585.
8. Vinatier D, Cosson M, Dufour P: Is endometriosis an endometrial disease? Eur J Obstet Gynecol Reprod Biol 2000; 91: 113-125.
9. Dmowski WP, Ding J, Shen J, Rana N, Fernandez BB, Braun DP: Apoptosis in endometrial glandular cells in women with and without endometriosis. Hum Reprod 2001; 16: 1802-1808.
10. Dmowski WP, Gebel HM, Braun DP: The role of cell-mediated immunity in pathogenesis of endometriosis. Acta Obstet Gynecol Scand 1994; 159: 7-14.
11. Koninckx PR, Oosterlynck D, D'Hooghe T, Meuleman C: Deeply infiltrating endometriosis is a disease whereas mild endometriosis could be considered a non-disease. Ann NY Acad Sci 1994; 734: 333-341.
12. Inagaki N, Ung I, Otani T, Wilkinson D, Lopata A: Uterine cavity matrix metalloproteinase and cytokines in patients with leiomyoma, adenomyosis or endometrial polyp. Eur J Obstet Gynecol Reprod Biol 2003; 111: 197-203.
13. Li T, Li YG, Pu DM: Matrix metalloproteinase-
14. and -9 expression correlated with angiogenesis in human adenomyosis. Gynecol Obstet Invest 2006; 62: 229-235.
15. Maeda N, Izumiya C, Yamamoto Y, Oguri H, Kusume T, Fukaya T: Increased killer inhibitory receptor KIR2DL1 expression among natural killer cells in women with pelvic endometriosis. Fertil Steril 2002; 77: 297-302.
16. Barrier BF, Kendall BS, Ryan CE, Sharpe- Timms KL: HLA-G is expressed by the glandular epithelium of peritoneal endometriosis but not in eutopic endometrium. Hum Reprod 2006; 21: 864-869.
17. Wang F, Wen Z, Li H, Yang Z, Zhao X, Yao X: Human leukocyte antigen-G is expressed by the eutopic and ectopic endometrium of adenomyosis. Fertil Steril 2008; 90: 1599- 1604.
18. Nakashima M, Sonoda K, Watanabe T: Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med 1999; 5: 938-942.
19. Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H: Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer. Gynecol Oncol 2005; 97: 772-779.
20. Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H: Invasive potency related to RCAS1 expression in uterine cervical cancer. Gynecol Oncol 2005; 99: 189-198.
21. Sonoda K, Miyamoto S, Nakashima M, Wake N: The biological role of the unique molecule RCAS1: a bioactive marker that induces connective tissue remodeling and lymphocyte apoptosis. Front Biosci 2008; 13: 1106-1116.
22. Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H: Clinical significance of RCAS1 as a biomarker of uterine cancer. Gynecol Oncol 2006; 103: 924-931.
23. Wicherek L, Popiela TJ, Galazka K, Dutsch- Wicherek M, Opławski M, Basta A, Klimek M: Metallothionein and RCAS1 expression in comparison to immunological cells activity in endometriosis, endometrial adenocarcinoma and the endometrium according to menstrual cycle changes. Gynecol Oncol 2005; 99: 622-630.
24. Wicherek L, Dutsch-Wicherek M, Galazka K, Banas T, Popiela T, Lazar A, Kleinrok- Podsiadlo B: Comparison of RCAS1 and metallothionein expression and the presence and activity of immune cells in human ovarian and abdominal wall endometriomas. Reprod Biol Endocrinol 2006; 4: 41.
25. Skret-Magierlo J, Wicherek L, Basta P, Galazka K, Sikora J, Wilk M, Fudali L, Skret A: RCAS1 decidual immunoreactivity during cesarean section in scar deciduosis: immune cell presence and activity. Gynecol Obstet Invest 2007; 65: 187-194.
26. Wicherek L: Alterations in RCAS1 serum concentration levels during the normal menstrual cycle and the lack of analogical changes in ovarian endometriosis. Am J Reprod Immunol 2008; 59: 535-544.
27. Bruner KL, Matrisian LM, Rodgers WH, Gorstein F, Osteen KG: Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. J Clin Invest 1997; 99: 2851-2857.
28. D'Hooghe TM, Bambra CS, Xiao L, Peixe K, Hill JA: Effect of menstruation and intrapelvic injection of endometrium on inflammatory parameters of peritoneal fluid in the baboon. Am J Obstet Gynecol 2001; 184: 917-925.
29. D'Hooghe TM, Hill JA, Oosterlynck DJ, Koninckx PR, Bambra CS: Effect of endometriosis on white blood cell subpopulations in the peripheral blood and peritoneal fluid of baboons. Hum Reprod 1996; 11: 1736-1740.
30. Meresman GF, Auge L, Baranao RI, Lombardi E, Tesone M, Sueldo C: Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis. Fertil Steril 2002; 77: 1141-1147.
31. Chung HW, Wen Y, Chun SH, Nezhat C, Woo BH, Lake Polan ML: Matrix metalloproteinase- 9 and tissue inhibitor of metalloproteinase- 3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness. Fertil Steril 2001; 75: 152-159.
32. Braundmeier AG, Nowak RA: Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer. Am J Reprod Immunol 2006; 56: 201-214.
33. Ulukus M, Ulukus EC, Seval Y, Cinar O, Zheng W, Arici A: Expression of interleukin- 8 receptors in patients with adenomyosis. Fertil Steril 2006; 85: 714-720.
34. Yang JH, Wu MY, Chang DY, Chang CH, Yang YS, Ho HN: Increased interleukin-6 messenger RNA expression in macrophagecocultured endometrial stromal cells in adenomyosis. Am J Reprod Immunol 2006; 55: 181-187.
35. Wang F, Li H, Yang Z, Du X, Cui M, Wen Z: Expression of interleukin-10 in patients with adenomyosis. Fertil Steril 2008, Epub ahead of print.
36. Ota H, Igarashi S, Kato N, Tanaka T: Aberrant expression of glutathione peroxidase in eutopic and ectopic endometrium in endometriosis and adenomyosis. Fertil Steril 2000; 74: 313-318.
37. Yang JH, Wu MY, Chen CD, Chen MJ, Yang YS, Ho HN: Altered apoptosis and proliferation in endometrial stromal cells of women with adenomyosis. Hum Reprod 2007; 22: 945-952.
38. Popiela TJ, Wicherek L, Radwan M, Sikora J, Banas T, Basta P, Kulczycka M, Grabiec M, Obrzut B, Kalinka J: The differences in RCAS1 and DFF45 endometrial expression between late proliferative, early secretory, and mid-secretory cycle phases. Fol Hist Cytochem 2007;(suppl 1):157-162.
39. Parazzini F, Vercellini P, Panazza S, Chatenoud L, Oldani S, Crosignani PG: Risk factors for adenomyosis. Hum Reprod 1997; 12: 1275-1279.
40. Yang JH, Chen MJ, Chen HF, Lee TH, Ho HN, Yang YS: Decreased expression of killer cell inhibitory receptors on natural killer cells in eutopic endometrium in women with adenomyosis. Hum Reprod 2004; 19: 1974- 1978.
41. Kitawaki J, Xu B, Ishihara H, Fukui M, Hasegawa G, Nakamura N, Mizuno S, Ohta M, Obayashi H, Honjo H: Association of killer cell immunoglobulin-like receptor genotypes with susceptibility to endometriosis. Am J Reprod Immunol 2007; 58: 481-486.
42. Wilczynski JR, Kalinka J, Radwan M: The role of the T-regulatory cells in pregnancy and cancer. Front Biosci 2008; 13: 2275- 2289.
43. Wilczynski JR, Radwan M, Kalinka J: The characterization and role of regulatory T cells in immune reactions. Front Biosci 2008; 13: 2266-2274.
44. Wicherek L: The role of the endometrium in the regulation of immune cell activity. Front Biosci 2008; 13: 1018-1035.
45. Dutsch-Wicherek M, Wicherek L: The association of RCAS1 serum concentration with the reversibility or irreversibility of the process of immune cytotoxic activity restriction during normal menstrual cycle, cancer relapse, and surgical treatment for various types of squamous cell carcinomas and adenocarcinomas. Am J Reprod Immunol 2008; 59: 266-275.
46. Wicherek L, Galazka K, Lazar A: The analysis of metallothionein, RCAS1 immunoreactivity regarding immune cells concentration in endometrium and tubal mucosa in ectopic pregnancy during the course of tubal rupture. Gynecol Obstet Invest 2007; 65: 52-61.